These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
563 related items for PubMed ID: 9647551
21. The influence of pharmaceutical compounds on male fertility. Neumann F, Diallo FA, Hasan SH, Schenck B, Traore I. Andrologia; 1976; 8(3):203-35. PubMed ID: 793446 [Abstract] [Full Text] [Related]
22. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Cooper AJ, Sandhu S, Losztyn S, Cernovsky Z. Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073 [Abstract] [Full Text] [Related]
23. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. Kamischke A, Venherm S, Plöger D, von Eckardstein S, Nieschlag E. J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016 [Abstract] [Full Text] [Related]
24. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. Gonzalo IT, Swerdloff RS, Nelson AL, Clevenger B, Garcia R, Berman N, Wang C. J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475 [Abstract] [Full Text] [Related]
25. Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment. McLachlan RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD, Bremner WJ, Meriggiola C. J Clin Endocrinol Metab; 2004 Jan; 89(1):142-9. PubMed ID: 14715841 [Abstract] [Full Text] [Related]
26. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. Wu FC, Balasubramanian R, Mulders TM, Coelingh-Bennink HJ. J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070 [Abstract] [Full Text] [Related]
27. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Soufir JC, Jouannet P, Marson J, Soumah A. Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496 [Abstract] [Full Text] [Related]
28. Suppression of spermatogenesis by testosterone enanthate in Thai men. Aribarg A, Sukcharoen N, Chanprasit Y, Ngeamvijawat J, Kriangsinyos R. J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996 [Abstract] [Full Text] [Related]
29. Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men. Foegh M, Nicol K, Petersen IB, Schou G. Contraception; 1980 Jun; 21(6):631-40. PubMed ID: 6775869 [Abstract] [Full Text] [Related]
30. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone. Swerdloff RS, Bagatell CJ, Wang C, Anawalt BD, Berman N, Steiner B, Bremner WJ. J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659 [Abstract] [Full Text] [Related]
31. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. Anderson RA, Wu FC. J Clin Endocrinol Metab; 1996 Mar; 81(3):896-901. PubMed ID: 8772547 [Abstract] [Full Text] [Related]
32. Suppression of human spermatogenesis by testosterone implants. Handelsman DJ, Conway AJ, Boylan LM. J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094 [Abstract] [Full Text] [Related]
33. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome. Falsetti L, Galbignani E. Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631 [Abstract] [Full Text] [Related]
34. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone. Matsumoto AM, Karpas AE, Paulsen CA, Bremner WJ. J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766 [Abstract] [Full Text] [Related]
35. Spermatogenesis in men treated with injections of medroxyprogesterone acetate combined with testosterone enanthate. Frick J, Danner C, Kunit G, Joos H, Köhle R. Int J Androl; 1982 Jun; 5(3):246-52. PubMed ID: 7118265 [Abstract] [Full Text] [Related]
36. Influence of testosterone substitution on sperm suppression by LHRH agonists. Bouchard P, Garcia E. Horm Res; 1987 Jun; 28(2-4):175-80. PubMed ID: 2969861 [Abstract] [Full Text] [Related]
37. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception. Brady BM, Walton M, Hollow N, Kicman AT, Baird DT, Anderson RA. Hum Reprod; 2004 Nov; 19(11):2658-67. PubMed ID: 15333595 [Abstract] [Full Text] [Related]
38. Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone. Behre HM, Kliesch S, Lemcke B, von Eckardstein S, Nieschlag E. Hum Reprod; 2001 Dec; 16(12):2570-7. PubMed ID: 11726576 [Abstract] [Full Text] [Related]
39. Relationship between hormone profiles and the restoration of spermatogenesis in men treated with gossypol. Gu ZP, Wang YX, Sang GW, Wang WC, Chen ZX, Zhao XJ, Shao QX, Jiang Y. Int J Androl; 1990 Aug; 13(4):253-7. PubMed ID: 2117586 [Abstract] [Full Text] [Related]
40. Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata). Shetty G, Krishnamurthy H, Krishnamurthy HN, Ramachandra SG, Moudgal NR. Contraception; 1997 Oct; 56(4):257-65. PubMed ID: 9408708 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]